157 related articles for article (PubMed ID: 28003103)
1. Retinopathy predicts progression of fasting plasma glucose: An Early Diabetes Intervention Program (EDIP) analysis.
Patel YR; Kirkman MS; Considine RV; Hannon TS; Mather KJ
J Diabetes Complications; 2017 Mar; 31(3):605-610. PubMed ID: 28003103
[TBL] [Abstract][Full Text] [Related]
2. Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).
Hannon TS; Kirkman MS; Patel YR; Considine RV; Mather KJ
Diabetes Metab Res Rev; 2014 Nov; 30(8):767-76. PubMed ID: 24819707
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.
Perais J; Agarwal R; Evans JR; Loveman E; Colquitt JL; Owens D; Hogg RE; Lawrenson JG; Takwoingi Y; Lois N
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013775. PubMed ID: 36815723
[TBL] [Abstract][Full Text] [Related]
4. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study.
Cikamatana L; Mitchell P; Rochtchina E; Foran S; Wang JJ
Eye (Lond); 2007 Apr; 21(4):465-71. PubMed ID: 17318200
[TBL] [Abstract][Full Text] [Related]
5. Changes in Weight and Glucose Can Protect Against Progression in Early Diabetes Independent of Improvements in β-Cell Function.
Patel YR; Kirkman MS; Considine RV; Hannon TS; Mather KJ
J Clin Endocrinol Metab; 2016 Nov; 101(11):4076-4084. PubMed ID: 27533307
[TBL] [Abstract][Full Text] [Related]
6. Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
Zoppini G; Verlato G; Targher G; Casati S; Gusson E; Biasi V; Perrone F; Bonora E; Muggeo M
Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):334-9. PubMed ID: 18571393
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of retinopathy in people with diabetes, impaired glucose tolerance, and normal glucose tolerance.
Rajala U; Laakso M; Qiao Q; Keinänen-Kiukaanniemi S
Diabetes Care; 1998 Oct; 21(10):1664-9. PubMed ID: 9773727
[TBL] [Abstract][Full Text] [Related]
8. Glycemic variability and diabetes retinopathy: a missing link.
Hsu CR; Chen YT; Sheu WH
J Diabetes Complications; 2015 Mar; 29(2):302-6. PubMed ID: 25534877
[TBL] [Abstract][Full Text] [Related]
9. Different retinopathy phenotypes in type 2 diabetes predict retinopathy progression.
Marques IP; Madeira MH; Messias AL; Martinho AC; Santos T; Sousa DC; Figueira J; Cunha-Vaz J
Acta Diabetol; 2021 Feb; 58(2):197-205. PubMed ID: 33025221
[TBL] [Abstract][Full Text] [Related]
10. Evaluations of retinopathy in the VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM). A feasibility study.
Emanuele N; Klein R; Abraira C; Colwell J; Comstock J; Henderson WG; Levin S; Nuttall F; Sawin C; Silbert C; Lee HS; Johnson-Nagel N
Diabetes Care; 1996 Dec; 19(12):1375-81. PubMed ID: 8941467
[TBL] [Abstract][Full Text] [Related]
11. Early detection of type 2 diabetes mellitus and screening for retinopathy are associated with reduced prevalence and severity of retinopathy.
Olafsdottir E; Andersson DK; Dedorsson I; Svärdsudd K; Jansson SP; Stefánsson E
Acta Ophthalmol; 2016 May; 94(3):232-9. PubMed ID: 26855250
[TBL] [Abstract][Full Text] [Related]
12. The Relationship of Retinal Vessel Geometric Characteristics to the Incidence and Progression of Diabetic Retinopathy.
Klein R; Lee KE; Danforth L; Tsai MY; Gangnon RE; Meuer SE; Wong TY; Cheung CY; Klein BEK
Ophthalmology; 2018 Nov; 125(11):1784-1792. PubMed ID: 29779685
[TBL] [Abstract][Full Text] [Related]
13. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses.
Liu QZ; Pettitt DJ; Hanson RL; Charles MA; Klein R; Bennett PH; Knowler WC
Diabetologia; 1993 May; 36(5):428-32. PubMed ID: 8314447
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of and risk factors for diabetic retinopathy in Koreans with type II diabetes: baseline characteristics of Seoul Metropolitan City-Diabetes Prevention Program (SMC-DPP) participants.
Park CY; Park SE; Bae JC; Kim WJ; Park SW; Ha MM; Song SJ
Br J Ophthalmol; 2012 Feb; 96(2):151-5. PubMed ID: 21775765
[TBL] [Abstract][Full Text] [Related]
15. Rationale, Design, Methodology and Baseline Data of Fushun Diabetic Retinopathy Cohort Study (FS-DIRECT).
Wang Y; Lin Z; Wen L; Rong SS; Ding XX; Li D; Feng KM; Wang FH; Liang YB; Zhai G
Ophthalmic Epidemiol; 2020 Feb; 27(1):73-82. PubMed ID: 31722595
[No Abstract] [Full Text] [Related]
16. Data collection on retinopathy as a public health tool: The Hubble telescope equivalent of looking back in time.
Constantino MI; Molyneaux L; Wu T; Twigg SM; Wong J; Yue DK
J Diabetes Complications; 2017 Apr; 31(4):721-725. PubMed ID: 28161385
[TBL] [Abstract][Full Text] [Related]
17. Risk factors associated with progression to referable retinopathy: a type 2 diabetes mellitus cohort study in the Republic of Ireland.
Smith JJ; Wright DM; Scanlon P; Lois N
Diabet Med; 2020 Jun; 37(6):1000-1007. PubMed ID: 32096253
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of diabetic retinopathy and nephropathy in Polynesians of Western Samoa.
Collins VR; Dowse GK; Plehwe WE; Imo TT; Toelupe PM; Taylor HR; Zimmet PZ
Diabetes Care; 1995 Aug; 18(8):1140-9. PubMed ID: 7587849
[TBL] [Abstract][Full Text] [Related]
19. The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program.
Diabetes Prevention Program Research Group
Diabet Med; 2007 Feb; 24(2):137-44. PubMed ID: 17257275
[TBL] [Abstract][Full Text] [Related]
20. Early risk stratification in pediatric type 1 diabetes.
Broe R
Acta Ophthalmol; 2015 Mar; 93 Thesis 1():1-19. PubMed ID: 25703648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
